MED12 and leiomyoma: The most prevalent alterations in conventional ULs were only rarely observed in leiomyomas with bizarre nuclei: MED12 mutations were identified in three out of 18 tumors (16.7%) and none displayed HMGA2 overexpression (Table 1, Fig. 1, see Additional file 6: Table S3).